The data shown below were collected from the profiles of 30 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
| Title |
Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension
|
|---|---|
| Published in |
Cochrane database of systematic reviews, October 2008
|
| DOI | 10.1002/14651858.cd003823.pub2 |
| Pubmed ID | |
| Authors |
Balraj S Heran, Michelle MY Wong, Inderjit K Heran, James M Wright |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 2 | 7% |
| United States | 1 | 3% |
| Unknown | 27 | 90% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 21 | 70% |
| Practitioners (doctors, other healthcare professionals) | 7 | 23% |
| Scientists | 1 | 3% |
| Science communicators (journalists, bloggers, editors) | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 273 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| South Africa | 2 | <1% |
| United Kingdom | 1 | <1% |
| Unknown | 270 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 43 | 16% |
| Student > Master | 41 | 15% |
| Student > Ph. D. Student | 28 | 10% |
| Researcher | 21 | 8% |
| Student > Doctoral Student | 15 | 5% |
| Other | 44 | 16% |
| Unknown | 81 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 94 | 34% |
| Pharmacology, Toxicology and Pharmaceutical Science | 21 | 8% |
| Nursing and Health Professions | 18 | 7% |
| Agricultural and Biological Sciences | 16 | 6% |
| Biochemistry, Genetics and Molecular Biology | 9 | 3% |
| Other | 23 | 8% |
| Unknown | 92 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 121. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 June 2024.
All research outputs
#363,753
of 26,378,648 outputs
Outputs from Cochrane database of systematic reviews
#582
of 13,210 outputs
Outputs of similar age
#737
of 104,882 outputs
Outputs of similar age from Cochrane database of systematic reviews
#2
of 68 outputs
Altmetric has tracked 26,378,648 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,210 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.6. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 104,882 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 68 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.